Latest period
$5.07B
YoY change
+9.2%
5Y CAGR
+7.6%
Peak year (1998)
$4.94B
Cumulative CapEx
$99.08B
CapEx history chart for Johnson & Johnson (JNJ) from 1989 to 2025
Latest: $4.83B
CapEx growth chart for Johnson & Johnson (JNJ) from 1989 to 2025
Latest: +9.2%
CapEx history table for Johnson & Johnson (JNJ) from 1989 to 2025
| 2025 | $4.83B | +9.2% | +$408.00M | ||
| 2024 | $4.42B | -2.6% | −$119.00M | ||
| 2023 | $4.54B | +13.3% | +$534.00M | ||
| 2022 | $4.01B | +9.8% | +$357.00M | ||
| 2021 | $3.65B | +9.1% | +$305.00M | ||
| 2020 | $3.35B | -4.3% | −$151.00M | ||
| 2019 | $3.50B | -4.7% | −$172.00M | ||
| 2018 | $3.67B | +11.9% | +$391.00M | ||
| 2017 | $3.28B | +1.6% | +$53.00M | ||
| 2016 | $3.23B | -6.8% | −$237.00M | ||
| 2015 | $3.46B | -6.8% | −$251.00M | ||
| 2014 | $3.71B | +3.3% | +$119.00M | ||
| 2013 | $3.60B | +22.5% | +$661.00M | ||
| 2012 | $2.93B | +1.4% | +$41.00M | ||
| 2011 | $2.89B | +21.4% | +$509.00M | ||
| 2010 | $2.38B | +0.8% | +$19.00M | ||
| 2009 | $2.37B | -22.9% | −$701.00M | ||
| 2008 | $3.07B | -7.4% | −$244.00M | ||
| 2007 | $3.31B | +20.9% | +$572.00M | ||
| 2006 | $2.74B | +4.0% | +$106.00M | ||
| 2005 | $2.63B | +21.0% | +$457.00M | ||
| 2004 | $2.17B | -3.8% | −$87.00M | ||
| 2003 | $2.26B | +7.8% | +$163.00M | ||
| 2002 | $2.10B | +21.3% | +$368.00M | ||
| 2001 | $1.73B | +5.2% | +$85.00M | ||
| 2000 | $1.65B | -17.7% | −$353.00M | ||
| 1999 | $2.00B | -59.5% | −$2.94B | ||
| 1998 | $4.94B | +255.2% | +$3.55B | ||
| 1997 | $1.39B | +1.3% | +$18.00M | ||
| 1996 | $1.37B | +9.3% | +$117.00M | ||
| 1995 | $1.26B | +34.0% | +$319.00M | ||
| 1994 | $937.00M | -3.9% | −$38.00M | ||
| 1993 | $975.00M | -11.6% | −$128.00M | ||
| 1992 | $1.10B | +11.8% | +$116.00M | ||
| 1991 | $987.00M | +18.9% | +$157.00M | ||
| 1990 | $830.00M | +10.7% | +$80.00M | ||
| 1989 | $750.00M | — | — |
- 2025$4.83B+9.2%
- 2024$4.42B-2.6%
- 2023$4.54B+13.3%
- 2022$4.01B+9.8%
- 2021$3.65B+9.1%
- 2020$3.35B-4.3%
- 2019$3.50B-4.7%
- 2018$3.67B+11.9%
- 2017$3.28B+1.6%
- 2016$3.23B-6.8%
- 2015$3.46B-6.8%
- 2014$3.71B+3.3%
- 2013$3.60B+22.5%
- 2012$2.93B+1.4%
- 2011$2.89B+21.4%
- 2010$2.38B+0.8%
- 2009$2.37B-22.9%
- 2008$3.07B-7.4%
- 2007$3.31B+20.9%
- 2006$2.74B+4.0%
- 2005$2.63B+21.0%
- 2004$2.17B-3.8%
- 2003$2.26B+7.8%
- 2002$2.10B+21.3%
- 2001$1.73B+5.2%
- 2000$1.65B-17.7%
- 1999$2.00B-59.5%
- 1998$4.94B+255.2%
- 1997$1.39B+1.3%
- 1996$1.37B+9.3%
- 1995$1.26B+34.0%
- 1994$937.00M-3.9%
- 1993$975.00M-11.6%
- 1992$1.10B+11.8%
- 1991$987.00M+18.9%
- 1990$830.00M+10.7%
- 1989$750.00M—
CapEx values are taken from Johnson & Johnson's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current CapEx (TTM) is $5.07B. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Johnson & Johnson (JNJ) reported CapEx of $4.83B – grew 9.2% year-over-year.
Johnson & Johnson CapEx has grown on net over the period, with a +7.6% compound annual growth rate over 2020–2025 (5 years).
Between 1998 and 2025, Johnson & Johnson CapEx edged down 2.2%, falling from $4.94B to $4.83B.
The highest annual CapEx of $4.94B was reported in 1998. The lowest in the available history was $750.00M in 1989.
Johnson & Johnson Capital Expenditures by Year
Johnson & Johnson Capital Expenditures 2025: $4.83B
Johnson & Johnson posted CapEx of $4.83B in 2025, grew 9.2% from 2024.
Johnson & Johnson Capital Expenditures 2024: $4.42B
In 2024, Johnson & Johnson reported CapEx of $4.42B, edged down 2.6% below 2023.
Johnson & Johnson Capital Expenditures 2023: $4.54B
Johnson & Johnson CapEx in 2023 was $4.54B, grew 13.3% from 2022.
Johnson & Johnson Capital Expenditures 2022: $4.01B
2022's CapEx for Johnson & Johnson came in at $4.01B, grew 9.8% from 2021.
Johnson & Johnson Capital Expenditures 2021: $3.65B
Johnson & Johnson CapEx in 2021 was $3.65B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers by CapEx
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.52B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation